Notice of Change to Page Limitation for Research Strategy Section for RFA-FD-12-014 Food Protection Rapid Response Team and Program Infrastructure Improvement Implementation Project (U18)

Notice Number: NOT-FD-12-015

Release Date: June 8, 2012

RFA-FD-12-014

U.S. Food and Drug Administration (FDA)

The purpose of this Notice is to change the page limitation for Research Strategy Section for RFA-FD-12-014.

Now Reads:

Section IV. Application and Submission Information

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed, with the following exception:

• For this specific FOA, the Research Strategy section is limited to 15 pages.

PHS 398 Research Plan Component

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

The applicant must specifically address, and will be judged on the following in the cooperative agreement application. Applications must include the following information in the Research Strategy attachment not to exceed 15 pages in length:

Should Read:

Section IV. Application and Submission Information

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed, with the following exception:

• For this specific FOA, the Research Strategy section is limited to 25 pages.

PHS 398 Research Plan Component

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

The applicant must specifically address, and will be judged on the following in the cooperative agreement application. Applications must include the following information in the Research Strategy attachment not to exceed 25 pages in length:

All other aspects of the FOA remain unchanged.

Please direct all inquiries to:

Lisa Ko
Grants Management Specialist
U.S. Food and Drug Administration
Office of Acquisition and Grants Services
5630 Fishers Lane Room 1096
Rockville, MD 20857
TEL: 301-827-5095
FAX: 301-827-1044
EMAIL: [email protected]